Patents by Inventor Duncan Hannah

Duncan Hannah has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compounds for promoting follicle maturation
    Publication number: 20230086706
    Abstract: Some analogues (eg. 3-carbamoyl-1-(tetrahydro-2H-pyran-4-yl)pyridin-1-ium, 3-carboxy-1-isopropylpyridin-1-ium, 1-benzyl-3-carbamoylpyridin-1-ium, 3-carbamoyl-1-methylpyridin-1-ium and cyclopamine) are disclosed to treat female infertility as the compounds increase the percentage of primary follicles relative to primordial follicles compared to control samples.
    Type: Application
    Filed: January 8, 2021
    Publication date: March 23, 2023
    Inventors: Karin Lykke-Hartmann, Gary Newton, Duncan Hannah, Robert Downham
  • 3-substituted 2-amino-indole derivatives
    Patent number: 10059713
    Abstract: The present invention provides compounds of formula (I) (Formula (I)) and pharmaceutically acceptable salts thereof, wherein Q, X % X4, X5 X6, X7, R1, R2, R3 and R8 are as defined in the specification, processes for the preparation of such compounds, pharmaceutical compositions containing them and the use of such compounds in therapy.
    Type: Grant
    Filed: June 24, 2015
    Date of Patent: August 28, 2018
    Assignee: TAKEDA PHARMACEUTICAL COMPANY LIMITED
    Inventors: Gregory Barker, Richard Davenport, Robert Downham, William Farnaby, Anne Goldby, Duncan Hannah, David Harrison, Henriette Willems
  • 1,3-SUBSTITUTED 2-AMINO-INDOLE DERIVATIVES AND ANALOGUES USEFUL IN THE TREATMENT OR PREVENTION OF DIABETES MELLITUS, OBESITY, AND INFLAMMATORY BOWEL DISEASE
    Publication number: 20170369492
    Abstract: The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof, wherein Q, X4, X5, X6, X7, R1, R2, R3 and R8 are as defined in the specification, processes for the preparation of such compounds, pharmaceutical compositions containing them and the use of such compounds in therapy.
    Type: Application
    Filed: June 24, 2015
    Publication date: December 28, 2017
    Inventors: Richard DAVENPORT, Jonathan DUNN, William FARNABY, Duncan HANNAH, David HARRISON, Susanne WRIGHT
  • 3-SUBSTITUTED 2-AMINO-INDOLE DERIVATIVES
    Publication number: 20170158700
    Abstract: The present invention provides compounds of formula (I) (Formula (I)) and pharmaceutically acceptable salts thereof, wherein Q, X % X4, X5 X6, X7, R1, R2, R3 and R8 are as defined in the specification, processes for the preparation of such compounds, pharmaceutical compositions containing them and the use of such compounds in therapy.
    Type: Application
    Filed: June 24, 2015
    Publication date: June 8, 2017
    Inventors: Gregory BARKER, Richard DAVENPORT, Robert DOWNHAM, William FARNABY, Anne GOLDBY, Duncan HANNAH, David HARRISON, Henriette WILLEMS
  • Novel Pyridine Derivatives, Processes for Preparing Them, Pharmaceutical Compositions Thereof
    Publication number: 20100168077
    Abstract: The present invention concerns 2-amino pyridine derivatives of formula 1 processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals.
    Type: Application
    Filed: March 31, 2008
    Publication date: July 1, 2010
    Applicant: UCB PHARMA, S.A.
    Inventor: Duncan Hannah
  • 2 Amino-Pyrimidine Derivatives As H4 Receptor Antagonists, Processes For Preparing Them And Their Use In Pharmaceutical Compositions
    Publication number: 20100035863
    Abstract: The present invention concerns novel 2 amino pyrimidine derivatives of formula (I), processes for preparing them, pharmaceutical compositions containing them and their use as harmaceuticals.
    Type: Application
    Filed: September 11, 2007
    Publication date: February 11, 2010
    Applicant: UCB PHARMA, S.A.
    Inventors: Gilles Raphy, Robert John Watson, Duncan Hannah, Cecile Pegurier, Isabelle Ortmans, Christopher James Lock, Roland Laurence Knight, David Alan Owen
  • Hydroxamic and carboxylic acid derivatives
    Patent number: 6506764
    Abstract: Compounds of the formula B—X—(CH2)m—CR1R2—(CH2)n—CO—Y  (I) have therapeutic utility as inhibitors of metalloproteinases etc.
    Type: Grant
    Filed: September 6, 2000
    Date of Patent: January 14, 2003
    Assignee: Darwin Discovery, Ltd.
    Inventors: Andrew Douglas Baxter, David Alan Owen, Duncan Hannah, John Gary Montana
  • Benzofuran-4-carboxamides and their therapeutic use
    Patent number: 6066657
    Abstract: A compound of formula (i) ##STR1## has therapeutic utility via inhibition of phosphodiesterase and THF release.
    Type: Grant
    Filed: February 9, 1999
    Date of Patent: May 23, 2000
    Assignee: Darwin Discovery, Ltd.
    Inventors: Hazel Joan Dyke, John Gary Montana, Christopher Lowe, Karen Ann Runcie, Alan Findlay Haughan, Verity Margaret Sabin, Duncan Hannah, Louise Picken, Andrew Sharpe